MK-1075

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-1075, covering 2018-11-13 to 2018-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002) [Phase 1]